HubSpot Inc header image

HubSpot Inc

HUBS

Equity

ISIN null / Valor 25302411

New York Stock Exchange, Inc (2026-02-19)
USD 239.37-4.31%

HubSpot Inc
UMushroom community rating:

star star star star star
4.53 7 votes No rating yet
NegativeNeutralPositive

About company

HubSpot Inc., under the leadership of CEO Yamini Rangan, has evolved from its initial focus on marketing to offer a comprehensive suite of products designed to enhance the customer experience. The company's cornerstone is its AI-powered Smart CRM platform, which is tailored to meet the needs of scaling organizations seeking to improve their growth metrics. HubSpot's offerings are not limited to marketing solutions; they encompass a range of tools aimed at creating seamless interactions between businesses and their customers. This strategic expansion into various facets of customer relationship management reflects HubSpot's commitment to providing integrated solutions that support the modern buyer's journey. Through its innovative approach and focus on leveraging artificial intelligence, HubSpot serves millions of users worldwide, helping them to navigate the complexities of customer engagement and business growth.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-69.0%1Y
-40.8%3Y
-56.0%5Y

Performance

52.2%1Y
43.2%3Y
53.0%5Y

Volatility

Market cap

12625 M

Market cap (USD)

Daily traded volume (Shares)

1,441,537

Daily traded volume (Shares)

1 day high/low

702.11 / 690.38

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.53

7 votes
Performance:
starstarstarstarstar
4.43
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
3.71
Nature:
starstarstarstarstar
4.00
Harry Capel
United Kingdom, 05 Nov 2025
star star star star star
Great innovation
Mustafa Arda Sis
United Kingdom, 03 Nov 2025
star star star star star
.
Hein Sweerts de Landas
Switzerland, 28 Nov 2023
star star star star star
Marketing + Cloud are two key ingredients of successful businesses these days, HubSpot seems to be positioned well to benefit. Reinforced by the decent upside potential as per the analysts.

EQUITIES OF THE SAME SECTOR

Kulicke & Soffa Industries Inc
Kulicke & Soffa Industries Inc Kulicke & Soffa Industries Inc Valor: 945945
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 69.46
Privia Health Group Inc
Privia Health Group Inc Privia Health Group Inc Valor: 111013233
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 21.83
Altair Engineering Inc
Altair Engineering Inc Altair Engineering Inc Valor: 38523645
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 111.85
TC Unterhaltungselektronik AG
TC Unterhaltungselektronik AG TC Unterhaltungselektronik AG Valor: 1124025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
25.00%EUR 0.1
MeVis Medical Solutions AG
MeVis Medical Solutions AG MeVis Medical Solutions AG Valor: 3537049
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.61%EUR 24.40
Belden Inc
Belden Inc Belden Inc Valor: 1878687
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.44%USD 144.62
Grifols, SA
Grifols, SA Grifols, SA Valor: 30689500
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.26%EUR 8.02
C3.ai Inc
C3.ai Inc C3.ai Inc Valor: 58396003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 10.70
Beam Therapeutics Inc
Beam Therapeutics Inc Beam Therapeutics Inc Valor: 50337226
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 27.88
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 480.52